435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squamous cell carcinoma

• Myung Ju Ahn,
• Lisa Licitra,
• Caroline Even,
• Chia-Jui Yen,
• George Blumenschein,
• Robin Meng,
• Giovanni Abbadessa,
• Fatima-Zohra Menas,
• Miao Zang

Affiliations

Myung Ju Ahn

Aff599 grid.264381.a000000012181989XSamsung Medical CenterSungkyunkwan University Seoul Republic of Korea

Lisa Licitra

Aff6 grid.417893.00000000108072568Fondazione IRCCS Instituto Nazionale dei Tumori Milan Italy

Caroline Even

Aff2 grid.14925.3b0000000122849388Institut Gustave-Roussy Villejuif France

Chia-Jui Yen

5 National Cheng Kung University Hospital, Tainan, Taiwan

George Blumenschein

University of Texas MD Anderson Cancer Center, Houston, TX, USA

Robin Meng

1Sanofi, Cambridge, USA

Giovanni Abbadessa

1Sanofi, Cambridge, USA

Fatima-Zohra Menas

1Sanofi, Cambridge, USA

Miao Zang

1Sanofi, Cambridge, USA